mately 20,000 participants in the
company's gene discovery programs. The SNPs, referred to as rs3796619 and
rs1670533, are within the RNF212 gene, and are estimated to account for
approximately 22% of paternal variability in recombination and 6.5% of
maternal variability. Little is known about RNF212, though it is a
mammalian homolog of a gene called ZHP-3 known to be crucial for the
success of recombination in other organisms. The paper, entitled 'Sequence
Variants in the RNF212 Gene Associate with Genomewide Recombination Rate,'
is published today in the online edition of Science, at
http://www.sciencemag.org/sciencexpress.
deCODE has made a number of breakthrough discoveries in the
understanding of recombination, fertility and human evolution. In 2002,
deCODE published the most detailed recombination map to date of the genome,
demonstrating that there are hotspots and coldspots for recombination in
all chromosomes, and that these are very different in women and men. This
map provided a template for completing the final assembly of the sequence
of the human genome. deCODE scientists then showed that recombination rate
varies between families and between women; that recombination rate
increases with the age of the mother; and that higher recombination rate
correlates with fertility, indicating that evolution appears to place a
premium on the generation of human diversity. In 2005, deCODE identified a
genetic variant that correlates with higher recombination rate, the first
genetic variant ever demonstrated to be under positive evolutionary
selection in human populations in real time. References for these and all
deCODE's major discoveries can be found at http://www.decode.com.
About deCODE
deCODE is a biopharmaceutical company applying its discoveries in human
genetics to the development of drugs and diagnostics for common disea
'/>"/>
SOURCE deCODE genetics Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference2.
deCODE Launches deCODEme(TM)3.
deCODE genetics Announces Third Quarter 2007 Financial Results4.
deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results5.
deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference6.
Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus7.
GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen8.
Healionics Corporation Announces Partnership to Develop and Distribute STARcuff(TM)9.
NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System10.
Nanotechnology innovation may revolutionize gene detection in a single cell11.
Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow